Gravitas Medical

Executive Summary

Gravitas Medical, a Houston-based medical device and digital health company founded in 2017, addresses a critical safety gap in enteral (tube) feeding—a procedure performed on millions of patients annually, where misplacement or dislodgement can lead to life-threatening complications. Its flagship Entarik Platform integrates real-time sensor guidance for accurate tube placement with continuous monitoring to detect dislodgement early. This smart platform aims to reduce adverse events, hospital costs, and clinician burden. By combining hardware and software, Gravitas positions itself at the intersection of patient safety and digital health. The company has not yet disclosed funding or revenue, but the growing emphasis on reducing hospital-acquired complications and the shift toward value-based care create a strong market pull. If successfully commercialized, the Entarik Platform could become a standard-of-care adjunct in acute and long-term care settings.

Upcoming Catalysts (preview)

• Q1 2027FDA 510(k) clearance for Entarik Platform70% success
• Q4 2026Pivotal clinical trial results demonstrating reduced misplacement rates60% success
• Q3 2026Hospital system partnership for pilot deployment50% success